Methyl 3-bromo-1H-indazole-6-carboxylate
CAS : 192945-56-5
Ref. 3D-SHA94556
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 25g | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Methyl 3-bromo-1H-indazole-6-carboxylate
Synonymes :
- 1H-Indazole-6-carboxylic acid, 3-bromo-, methyl ester
- Methyl 3-bromoindazole-6-carboxylate
Description :
Methyl 3-bromo-1H-indazole-6-carboxylate is a bile acid homeostasis activator that belongs to the class of small molecules. It has been shown to have anti-inflammatory and antiobesity effects, which are mediated by the activation of peroxisome proliferator activated receptor alpha. Methyl 3-bromo-1H-indazole-6-carboxylate has also been shown to be effective in reducing nonalcoholic steatohepatitis (NASH) in a mouse model and is being developed as a treatment for NASH. The drug is currently under development by Janssen and is currently in Phase 1 clinical trials.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
255.07 g/mol
Formule :
C9H7BrN2O2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
